Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance.
105 - 111.
Background: While the role of insulin in glucose uptake and its aberration in diabetes are well established, the effect of insulin on lipoprotein clearance in the postprandial phase is not yet fully understood. The dietary lipids are carried in chylomicron remnants (CR) which are taken up into the liver mainly via LDLR-related protein 1 (LRP1). In this study, the effect of insulin on LRP1-mediated hepatic CR uptake was investigated.Methods: The study was based on determining the subcellular localisation of LRP1 by subcellular fractionation and immunofluorescence microscopy and Correlating those findings with the hepatic uptake of fluorescently or radioactively labelled LRP1-specific ligands and CR in hepatoma cells, primary hepatocytes and mouse models.Results and conclusion: In vitro and in vivo, insulin stimulated the translocation of hepatic LRP1 from intracellular vesicles to the plasma membrane, which correlates with an increased uptake of LRP1-specific ligands. In wild-type mice, a glucose-induced insulin response increased the hepatic uptake of LRP1 ligands while in leptin-deficient obese mice (ob/ob), which are characterised by hepatic insulin resistance, insulin-inducible LRP1 ligand uptake was abolished. Finally, upon hepatic LRP1 knockdown, insulin no longer significantly enhanced CR uptake into the liver. The insulin-induced LRP1-mediated CR uptake, as demonstrated here, Suggests that impaired hepatic LRP1 translocation can contribute to the postprandial lipaemia in insulin resistance. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
|Title:||Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance|
|Keywords:||Lipoprotein metabolism, Low density lipoprotein receptor-related protein 1, LRP1, Insulin, Insulin resistance, Postprandial lipaemia, TRIGLYCERIDE-RICH LIPOPROTEINS, IN-VIVO, APOLIPOPROTEIN-E, ALPHA-2-MACROGLOBULIN RECEPTOR, ENRICHED LIPOPROTEINS, MATRIX PROTEOGLYCANS, RNA INTERFERENCE, LIPASE, DYSLIPIDEMIA, MICE|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
Archive Staff Only